Linda Johnson

AP Business Writer
Latest in Home
Strengthen Your Manufacturing Sales Resiliency
Sponsored
Strengthen Your Manufacturing Sales Resiliency
July 1, 2026
Volkswagen
Volkswagen CEO Warns of 50K Additional Job Cuts
July 20, 2026
Engine
Auto Supplier's Michigan Expansion to Tackle New Gas-Powered Engine
July 20, 2026
Thunder Defense Variant Front (3)
Anduril, Archer Unveil Jointly Developed Autonomous VTOL Airplane
July 20, 2026
Related Stories
Mnet 191142 3 D Printing
Quality Control
3D Printer Maker Seeks To Stop Bootlegged Designs
Mnet 63896 Flying Scotsman 3 Ap
Global
Photos Of The Day: The Historic Flying Scotsman’s Return To The Rails
Mnet 191134 Lexus
Quality Control
Study: Lexus, Porsche And Buick Are Most Dependable
Strengthen Your Manufacturing Sales Resiliency
Sponsor Content
Strengthen Your Manufacturing Sales Resiliency
More from Linda Johnson
Strengthen Your Manufacturing Sales Resiliency
Sponsored
Strengthen Your Manufacturing Sales Resiliency
Discover manufacturing sales and marketing strategies for today’s volatile market. Get guide now!
July 1, 2026
In this Wednesday, Oct. 7, 2020, file photo, a vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021.
Quality Control
New COVID Shot 90% Effective
The Novavax vaccine is easy to transport and store.
June 14, 2021
A vial with the Johnson & Johnson's one-dose COVID-19 vaccine is seen at the Vaxmobile, at the Uniondale Hempstead Senior Center, Wednesday, March 31, 2021, in Uniondale, N.Y. The Vaxmobile, is a COVID-19 mobile vaccination unit, sponsored by a partnership between Mount Sinai South Nassau and Town of Hempstead to bring the one-dose vaccine directly to hard-hit communities in the area.
Quality Control
J&J Vaccine Batch Fails Quality Check
The company said it still expects to deliver more than 1 billion vaccine doses globally by the end of the year.
April 1, 2021